Viz.ai Raises $71M To Expand Its AI Software Beyond Stroke Diagnosis

Israeli medical imaging startup Viz.ai, which helps doctors diagnose strokes through AI software, has raised a $71 million funding round, the company announced on Wednesday.

The round was led by Insight Partners and Scale Venture Partners, with the participation of Greenoaks Capital Partners LLC. Charles River Ventures (CRV), Threshold Ventures, Kleiner Perkins, Innovation Endeavors, and SOSA Ventures. 

This brings the company’s total funding raised to more than $150 million.

Founded in 2016, Viz.ai is a medical imaging company that helps optimize emergency treatment using deep learning technology to analyze CT scans and automatically detect and alert physicians of early signs of large vessel occlusion strokes through its Viz LVO platform. The tech introduced the concept of computer-aided triage software, which helps triage patients connect directly to a stroke specialist and fast-track life-saving care.

The company said it “aims to accelerate the expansion of its Intelligent Care Coordination AI platform beyond stroke to other areas of acute care such as cardiology, pulmonary and trauma, and into new global markets.”

“This expansion addresses the gap in the coordination of care among clinicians and healthcare systems to best facilitate essential and timely patient care,” said Rory O’Driscoll, partner, Scale Venture Partners. “Viz.ai has proven its ability to transform care coordination in stroke by leveraging AI and advanced mobile technology, and we see huge potential for this platform to transform other acute care specialties across healthcare.”

“Viz.ai has taken an innovative approach to transforming one of healthcare’s biggest challenges, using intuitive technology to help improve patient outcomes in acute care,” said Nikhil Sachdev, managing director of Insight Partners.

“We see the company poised for massive growth as it scales its clinically-verified stroke care coordination system to other use cases where time is crucial to outcomes and costs to patients and hospitals can exponentially increase when care coordination breaks down. We are looking forward to rolling up our sleeves and helping Viz.ai scale up,” he added.

“This latest round of funding validates the potential of Viz.ai’s technology, both in and beyond stroke care coordination,” said Chris Mansi, co-founder and CEO of Viz.ai. “The investment will allow us to expedite our effort to bring the power of artificial intelligence and advanced mobile technology to prevent care breakdowns, improve patient outcomes and experience, and improve economics across the entire health system both in the United States and Europe.”